好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Simulation training in Neuropalliative Care
Palliative Care
P8 - Poster Session 8 (11:45 AM-12:45 PM)
7-002
The purpose of our study is to evaluate if a simulation in neuropalliative care is a useful training method for neurology residents.
好色先生 in palliative care is lacking in neurology training. The majority of neurology residency programs do not have a formal way to train and assess residents in this domain.
The simulation targeted adult and pediatric Neurology residents ranging from PGY2- PGY4. The Serious Illness Conversation Guide (SICG) was used as a framework. Residents first received a didactic reviewing the SICG, followed by two simulations with standardized patients (SPs). The first simulation focused on giving bad news in the outpatient setting. The second focused on shared decision making in the inpatient setting. Residents filled out surveys assessing their comfort levels before and after the simulations, as well as 3 months later to determine how it influenced their practice.

Twenty-one residents participated in the simulation. Survey responses were received from 100% of participants. After the simulation, respondents who felt comfortable giving bad news increased by 11% for the inpatient setting and by 19% for the outpatient setting. There was a trend towards improved comfort in assessing illness understanding, managing uncertainty in prognosis, making a recommendation based on patient goals, and discussing hospice options. Overall, 91% thought the simulation accurately represented real life and 100% felt that the simulation would influence their future practice. At 3 months after the simulation, 85% of trainees reported using the SICG in palliative care conversations.
Simulation training with SPs is a valuable way to train neurology residents in neuropalliative care discussions. Future simulations can tailor specific scenarios to resident level of training.
Authors/Disclosures
Rakhee Lalla, DO
PRESENTER 		Dr. Lalla has received personal compensation in the range of $0-$499 for serving as a Consultant for Women's health initiative .
No disclosure on file
Stephanie L. Bissonnette, DO The institution of Dr. Bissonnette has received research support from SAGE Therapeutics. The institution of Dr. Bissonnette has received research support from Huntington's Disease Society of America. The institution of Dr. Bissonnette has received research support from CHDI Foundation.
K. H. Vincent Lau, MD (Boston Medical Center) Dr. Lau has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Lau has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for mctlaw. Dr. Lau has stock in Alnylam Pharmaceuticals.
No disclosure on file
Michelle Kaku, MD (Icahn School of Medicine at Mount Sinai, Neurology Dept.) Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.